Pfizer Inc (PFE)

Sector: Healthcare
Industry: Pharmaceutical Preparations
Country: United States
Exchange: NYSE
Market cap: $156.97B
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Latest financial period: September 27, 2026
Filed with the SEC: November 3, 2026
Estimated earnings date: February 2, 2027
Profit #946 of 1422 companies
| | Sep 26 | Jun 26 | Mar 26 | Dec 25 |
|---|
| ROE/ROA | 32.7% | 35.3% | 39.2% | 41.2% |
Growth #1152 of 1422 companies
Payout #723 of 1422 companies
Safety #747 of 1422 companies
Price #624 of 1422 companies